LEADER 01906nam 2200421 450 001 9910138154503321 005 20231130182233.0 010 $a953-51-6497-X 035 $a(CKB)3230000000075527 035 $a(NjHacI)993230000000075527 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/65160 035 $a(EXLCZ)993230000000075527 100 $a20221010d2011 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aAmyloidosis $emechanisms and prospects for therapy /$fedited by Svetlana Sarantseva 210 $cIntechOpen$d2011 210 1$aRijeka, Croatia :$cInTech,$d[2011] 210 4$dİ2011 215 $a1 online resource (228 pages) 311 $a953-307-253-9 330 $aAmyloidoses are a heterogeneous group of diverse etiology diseases. They are characterized by an endogenous production of abnormal proteins called amyloid proteins, which are not hydrosoluble, form depots in various organs and tissue of animals and humans and cause dysfunctions. Despite many decades of research, the origin of the pathogenesis and the molecular determinants involved in amyloid diseases has remained elusive. At present, there is not an effective treatment to prevent protein misfolding in these amyloid diseases. The aim of this book is to present an overview of different aspects of amyloidoses from basic mechanisms and diagnosis to latest advancements in treatment. 517 $aAmyloidosis 606 $aAmyloidosis 610 $aInfectious & contagious diseases 615 0$aAmyloidosis. 676 $a616.3995 700 $aSarantseva$b Svetlana$4edt$01439615 702 $aSarantseva$b Svetlana 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910138154503321 996 $aAmyloidosis$93601912 997 $aUNINA